Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Non-Small-Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Large-scale testing (Phase 3)Looking for participantsNCT07170995
What this trial is testing

Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Advanced or Metastatic Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 460
Not applicableStudy completedNCT03761901
What this trial is testing

Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 141
Testing effectiveness (Phase 2)Looking for participantsNCT07467863
What this trial is testing

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerAdvanced/Metastatic NSCLC
Beijing Biotech 48
Testing effectiveness (Phase 2)Study completedNCT00047840
What this trial is testing

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
Genzyme, a Sanofi Company 129
Testing effectiveness (Phase 2)Active Not RecruitingNCT05949606
What this trial is testing

SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 95
Early research (Phase 1)Study completedNCT01199068
What this trial is testing

CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Daiichi Sankyo Co., Ltd. 15
Testing effectiveness (Phase 2)Ended earlyNCT02408016
What this trial is testing

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Who this might be right for
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung Carcinoma+8 more
Fred Hutchinson Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT00006484
What this trial is testing

Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)Ended earlyNCT00551733
What this trial is testing

Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
CTI BioPharma 450
Large-scale testing (Phase 3)Study completedNCT00364351
What this trial is testing

Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 1,574
Testing effectiveness (Phase 2)Study completedNCT00005037
What this trial is testing

Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center 51
Large-scale testing (Phase 3)Active Not RecruitingNCT06497556
What this trial is testing

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerKRAS G12C Lung Cancer
Hoffmann-La Roche 338
Testing effectiveness (Phase 2)UnknownNCT04811001
What this trial is testing

Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations

Who this might be right for
NSCLC
Fondazione Ricerca Traslazionale 170
Large-scale testing (Phase 3)UnknownNCT04951648
What this trial is testing

A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 220
Testing effectiveness (Phase 2)Ended earlyNCT02954991
What this trial is testing

Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Mirati Therapeutics Inc. 161
Testing effectiveness (Phase 2)Study completedNCT02039674
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)

Who this might be right for
Non-small Cell Lung Carcinoma
Merck Sharp & Dohme LLC 267
Testing effectiveness (Phase 2)UnknownNCT04956146
What this trial is testing

Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
The First Affiliated Hospital with Nanjing Medical University 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT07383116
What this trial is testing

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non Squamous Non-small Cell Lung Cancer
Shanghai Huaota Biopharmaceutical Co., Ltd. 500
Early research (Phase 1)Study completedNCT04177290
What this trial is testing

A PK Similarity Study of Two Sintilimab Products Produced by Different Processes in Advanced or Metastatic NSCLC Patients

Who this might be right for
Advanced or Metastatic NSCLC
Innovent Biologics (Suzhou) Co. Ltd. 48
Next Page